Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.

Gao, Chao; Liu, Shu-Guang; Lu, Wen-Ting; Yue, Zhi-Xia; Zhao, Xiao-Xi; Xing, Tian-Yu; Chen, Zhen-Ping; Zheng, Hu-Yong; Li, Zhi-Gang

Gao, Chao; Liu, Shu-Guang; Lu, Wen-Ting; Yue, Zhi-Xia; Zhao, Xiao-Xi; Xing, Tian-Yu; Chen, Zhen-Ping; Zheng, Hu-Yong; Li, Zhi-Gang.

Affiliation

Gao C; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Liu SG; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Lu WT; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Yue ZX; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Zhao XX; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Xing TY; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Chen ZP; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Zheng HY; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
Li ZG; Hematology and Oncology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, P.R. China.

Mol Med Rep ; 22(4): 2905-2915, 2020 Oct.

Article de En | MEDLINE | ID: mdl-32945392

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Daunorubicine / Régulation négative / Résistance aux médicaments antinéoplasiques / Prolifération cellulaire / Protéine CBP / Leucémie-lymphome lymphoblastique à précurseurs B et T / Points de contrôle du cycle cellulaire / Antibiotiques antinéoplasiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Med Rep Année: 2020 Type de document: Article Pays de publication: Grèce

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google